Deranged α-Adrenergic Regulation of Growth Hormone Secretion in Poorly Controlled Diabetes: Reversal of the Exaggerated Response to Clonidine after Continuous Subcutaneous Insulin Infusion
Deranged α-Adrenergic Regulation of Growth Hormone Secretion in Poorly Controlled Diabetes: Reversal of the Exaggerated Response to Clonidine after Continuous Subcutaneous Insulin Infusion
复制标题
控制不佳的糖尿病中生长激素分泌的α-肾上腺素能调节紊乱:连续皮下胰岛素输注后对可乐定的过度反应的逆转
作者:
E. Topper;J. Gertner;S. Amiel;M. Press;M. Genel;W. Tamborlane
ABSTRACT: Elevated plasma growth hormone (GH) and peripheral catecholamine levels are frequently observed in poorly controlled, insulin-dependent diabetes. Since the alpha adrenergic system plays an important role in hypothalamic regulation of GH secretion, we tested the hypothesis that altered central adrenergic activity contributes to the increased GH concentrations in diabetes. Clonidine, an α-adrenergic agonist, was administered to nine poorly controlled, young diabetic patients (age 12–19 yr) before and after 1 wk of continuous subcutaneous insulin infusion pump therapy. As expected, continuous subcutaneous insulin infusion lowered mean 24-h plasma glucose (from 203 ± 21 to 112 ± 7 mg/dl,p < 0.01) and GH (from 17.7 ± 2.1 to 9.2 ±1.2 ng/ml, p < 0.01) to values observed in normal controls. In the diabetic patients during conventional treatment, both the peak plasma GH level postclon-idine (48.3 ± 8.7 ng/ml) and the incremental area under the GH response curve (3.23 ± 0.58 mgmin/ml) were significantly increased above normal control values (25.2 ± 2.1 ng/ml, p < 0.05 and 1.63 ± 0.11 mgmin/ml, p ± 0.0025, respectively). In contrast, the GH response to clonidine was indistinguishable from normal after only 1 wk of intensified insulin treatment. Our findings support the contention that metabolic control of diabetes influences hypothalamic regulation of GH secretion and suggests that such alterations are related, at least in part, to changes in central α-adrenergic activity.
DOI:
10.1056/nejm198403293101302
发表时间:
1984
期刊:
The New England journal of medicine
影响因子:
--
作者:
Press,M;Tamborlane,WV;Sherwin,RS
通讯作者:
Sherwin,RS
DOI:
10.1056/nejm198403293101307
发表时间:
1984
期刊:
The New England journal of medicine
影响因子:
--
作者:
Rabin,D;Bloomgarden,ZT;Feman,SS;Davis,TQ
通讯作者:
Davis,TQ